Provided by Tiger Trade Technology Pte. Ltd.

AtriCure

59.12
+1.983.47%
Post-market: 59.120.00000.00%18:13 EDT
Volume:1.54M
Turnover:90.66M
Market Cap:2.99B
PE:280.41
High:59.59
Open:57.96
Low:57.31
Close:57.14
52wk High:59.59
52wk Low:25.36
Shares:50.63M
Float Shares:48.59M
Volume Ratio:1.31
T/O Rate:3.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2108
EPS(LYR):-0.2400
ROE:2.15%
ROA:1.25%
PB:5.80
PE(LYR):-246.33

Loading ...

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Atricure (ATRC) and Stryker (SYK)

TIPRANKS
·
Yesterday

AtriCure, Inc. : Stifel Raises Target Price to $65 from $50

THOMSON REUTERS
·
Yesterday

U.S. Research Roundup-Celcuity, Fluence Energy, Salesforce

Reuters
·
Yesterday

AtriCure CTO Salvatore Privitera Sells 3,657 Shares for $201,135

Reuters
·
Sep 10

S&P 500 to Add Bloom Energy, Illumina and Everpure in September Rebalance

Tiger Newspress
·
Sep 05

AtriCure CTO Salvatore Privitera Sells 7,763 Shares Worth $407,558

Reuters
·
Sep 04

Needham Raises Price Target on AtriCure to $64 From $45, Keeps Buy Rating

MT Newswires Live
·
Sep 02

AtriCure is Maintained at Buy by Needham

Dow Jones
·
Sep 02

AtriCure, Inc. : Needham Raises Target Price to $64 from $45

THOMSON REUTERS
·
Sep 02

AtriCure is Maintained at Overweight by Piper Sandler

Dow Jones
·
Aug 28

U.S. Research Roundup-CrowdStrike, Nvidia, Macerich

Reuters
·
Aug 27

AtriCure Chief Legal Officer Karl S. Dahlquist Sells 9,370 Shares for $458,069.30

Reuters
·
Aug 26

AtriCure to Join Wells Fargo Health Care Conference Fireside Chat

Reuters
·
Aug 25

AtriCure is Maintained at Buy by BTIG

Dow Jones
·
Aug 24

AtriCure (ATRC) Is Up 10.1% After Unveiling 2030 Revenue Goal And Trial-Driven Expansion Plans

Simply Wall St.
·
Aug 15

AtriCure (ATRC) Lifted Its Guidance, Is The Stock Fully Priced?

Simply Wall St.
·
Aug 10

AtriCure Director Maggie Yuen Sells 3,500 Shares Worth $134,470

Reuters
·
Aug 07

AtriCure Chief Scientific Officer Vinayak Doraiswamy Disposes of $233,280 in Common Shares

Reuters
·
Jul 31

UBS Adjusts Price Target on AtriCure to $50 From $55, Maintains Buy Rating

MT Newswires Live
·
Jul 28

AtriCure Q2 Net Income Turns to USD 8.96 Million; Revenue Rises 12.8% to USD 153.6 Million Year over Year

Reuters
·
Jul 28